You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Tecnotree Q1'24: Headwinds from the currency exchange rates
Tecnotree continued its growth trend in the first quarter of the year. Currency exchange rates remained a headwind, but the company continues its collaboration with several financial institutions to mitigate currency losses through currency exchange agreements and hedging. Tecnotree’s CEO Padma Ravichander and CFO Indiresh Vivekananda commented on this in an interview with analyst Roni Peuranheimo.
Content:
00:00 Intro
00:20 Highlights of Q1
05:47 Revenue
07:04 Order backlog
07:59 Seasonality of cash flows
09:04 M&A plans
09:56 Dividend
11:33 Management compensations
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Vis alle videoer